Adar Poonawalla, CEO of Serum Institute of India (SII) the world’s biggest vaccine manufacturer, says that India may face vaccine shortages for the next few months.
The existing capacity of 60-70 million a month will only increase to 100 million doses by July. Earlier the company had not increased capacity due to lack of orders. This highlights severe vaccine shortage for now.
The government had also paid Rs 3,000 crores as an advance to SII for ramping up the vaccine supplies. Currently, India is in the grip of a deadly second wave of coronavirus.
The SII in collaboration with AstraZeneca and Oxford University will now manufacture the coronavirus vaccine.
His manufacturing facility, Serum Institute, is producing Covshield, one of two COVID-19 vaccines that are in use for mass inoculation in India.
Earlier the Supreme Court of India had also asked about the differential pricing of vaccines in the country.
Why should there be two prices for the Centre and states? Making it amply clear that the judiciary comes into the picture when citizens’ rights are concerned. The court also cleared the air on its aim to intervene here.